NCT04050163View on ClinicalTrials.gov

MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions

Myocardial Infarction

Interventions

BIOLOGICAL

MiSaver®

Intravenous administration of MiSaver® Stem Cell via peripheral vein access.

Trial Locations (2)

402

Chung Shan Medical University Hospital, Taichung

74147

HONYA Medical Inc, Tainan City

Sponsors

Lead Sponsor

Honya Medical Inc

All Listed Sponsors

collaborator

Chung Shan Medical University

OTHER

lead

Honya Medical Inc

INDUSTRY